These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 14461265)

  • 1. [The Owren thrombotest. Value and technic].
    LABIGNETTE P
    Concours Med; 1962 Jun; 84():3701-2. PubMed ID: 14461265
    [No Abstract]   [Full Text] [Related]  

  • 2. [The thrombotest of Owren].
    de VRIES S; ABELS J; HAANEN CA; LOELIGER EA
    Ned Tijdschr Geneeskd; 1961 May; 105():977-80. PubMed ID: 13782237
    [No Abstract]   [Full Text] [Related]  

  • 3. [The Owren thrombotest. Its importance in the control of anticoagulant treatment].
    RINGENBACH G
    J Med Bord; 1962 Jun; 139():731-9. PubMed ID: 14492359
    [No Abstract]   [Full Text] [Related]  

  • 4. [The Owren thrombotest as a hepatic function test].
    FERRARI A; SCALVINI A
    Riforma Med; 1962 Jan; 76():76-80. PubMed ID: 13892482
    [No Abstract]   [Full Text] [Related]  

  • 5. [TRIALS ON THE CAPILLARY BLOOD METHOD FOR THE CONTROL OF ANTICOAGULANT THERAPY: THE OWREN THROMBOTEST AND HARTERT PROTHROMBIN TIME].
    FISCHER M
    Thromb Diath Haemorrh; 1964 Apr; 11():243-53. PubMed ID: 14167109
    [No Abstract]   [Full Text] [Related]  

  • 6. [THE THROMBOTEST (OWREN). CONTROL OF ANTICOAGULANT THERAPY IN PRACTICE].
    HANSEN KJ; JUHL F
    Internist Prax; 1965; 5():139-42. PubMed ID: 14281296
    [No Abstract]   [Full Text] [Related]  

  • 7. OBSERVATIONS ON THE USE OF THE BECTON DICKINSON FIBROMETER.
    WYLIE CR; FRASER C
    J Clin Pathol; 1965 May; 18(3):372-4. PubMed ID: 14304257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EFFECT OF PREGNANCY OR A PROGESTATIONAL DRUG ON BLOOD COAGULATION AS MEASURED BY THE THROMBOTEST.
    BRODSKY I; LEWIS G; ROSS E
    Obstet Gynecol; 1964 Aug; 24():213-7. PubMed ID: 14199527
    [No Abstract]   [Full Text] [Related]  

  • 9. [THROMBOTEST AS AN INDEX TO THE BLOOD COAGULABILITY IN CEREBROVASCULAR DISORDERS].
    MITROPOLSKII BA
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1964; 64():1470-3. PubMed ID: 14328169
    [No Abstract]   [Full Text] [Related]  

  • 10. [BLOOD COAGULATION IN THE STUDY OF HEPATIC FUNCTION. SIGNIFICANCE OF OWREN'S THROMBOTEST IN THE COURSE OF SOME LIVER DISEASES].
    BARTOLETTI L; BERNI G; DONI A; SCARPELLI PT; VANNUCCHI V
    Riv Crit Clin Med; 1963 Apr; 63():55-74. PubMed ID: 14277812
    [No Abstract]   [Full Text] [Related]  

  • 11. [The thrombotest].
    FUJIMAKI M
    Rinsho Byori; 1962 Aug; 10():435-6. PubMed ID: 13963164
    [No Abstract]   [Full Text] [Related]  

  • 12. Christmas factor in thrombotest.
    OWREN PA
    Lancet; 1960 Feb; 1(7121):436. PubMed ID: 14429571
    [No Abstract]   [Full Text] [Related]  

  • 13. [The thrombotest of Owren: a comparison with other methods of control for treatment with anticoagulants with indirect effect].
    ABELS J; GROEN A; NIEWEG HO
    Ned Tijdschr Geneeskd; 1962 May; 106():929-35. PubMed ID: 13858929
    [No Abstract]   [Full Text] [Related]  

  • 14. [The Owren thrombotest, a new method for the control of indirect anticoagulant therapy. Experimental research].
    GOBBI F; ASCARI E; BARBIERI U
    Minerva Med; 1961 Aug; 52():2754-60. PubMed ID: 13706150
    [No Abstract]   [Full Text] [Related]  

  • 15. [Possibilities of application of the Owren thrombotest in the control of therapy with indirect anticoagulants].
    PUNTURIERI E; RICCI N; BOSI L
    Riforma Med; 1962 Mar; 76():307-10. PubMed ID: 14489227
    [No Abstract]   [Full Text] [Related]  

  • 16. [Owren's thrombotest and control of anticoagulant treatment].
    RINGENBACH G
    Presse Med (1893); 1962 Jun; 70():1446-8. PubMed ID: 14492358
    [No Abstract]   [Full Text] [Related]  

  • 17. Advantages and practicality of Owren's thrombotest with thoughts on anticoagulation in general.
    GAMBLE WS
    J Maine Med Assoc; 1962 Mar; 53():60-4. PubMed ID: 13896559
    [No Abstract]   [Full Text] [Related]  

  • 18. [Preliminary results of an investigation into the significance of Owren's thrombotest as a control method in therapy with oral anticoagulants].
    FREDERIKS PW
    Ned Tijdschr Geneeskd; 1962 Jun; 106():1237-41. PubMed ID: 13894827
    [No Abstract]   [Full Text] [Related]  

  • 19. [The thrombotest in the normal infant: response to vitamin K].
    Leggio ML; Cattaneo F; Masera G
    Minerva Pediatr; 1968 Jul; 20(28):1458-61. PubMed ID: 5705349
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison and evaluation of a Point-of-care device (CoaguChek XS) to Owren-type prothrombin time assay for monitoring of oral anticoagulant therapy with warfarin.
    Wieloch M; Hillarp A; Strandberg K; Nilsson C; Svensson PJ
    Thromb Res; 2009 Jul; 124(3):344-8. PubMed ID: 19423152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.